California's drug label, CalRx, is teaming up with Amneal Pharmaceuticals to offer naloxone at a 40% discount, Gov. Gavin Newsom said April 29.

Pfizer's first FDA-approved gene therapy is one of the most expensive medications in the U.S.

As some formularies begin to favor biosimilars, CVS Health and Cigna Group's Evernorth are veering further into the biosimilar business, The Wall Street Journal reported April 29. 

The term "hospital pharmacy" is becoming a misnomer.

In the first three months of 2024, the U.S. reached a record with 323 ongoing medication shortages — the highest number since 2001. 

West Reading, Pa.-based Tower Health recently promoted Stephanie Goldman, PharmD, from a hospital pharmacy leadership role to a systemwide job. 

Walgreens is expanding its specialty pharmacy offerings, including gene and cell therapy services, the company said April 25. 

Keytruda (pembrolizumab) was nonfederal hospitals' costliest drug expense in 2023, according to research published April 24 in the American Journal of Health-System Pharmacy. 

More than $38 billion was spent in the U.S. on Ozempic and Wegovy (semaglutide) in 2023 — a 100% uptick from 2022 expenditure data, according to research published April 24 in the American Journal of Health-System Pharmacy. 

The American Society of Health-System Pharmacists has named eight candidates for its board of directors.

Eli Lilly will acquire a Wisconsin-based injectable manufacturing facility from Nexus Pharmaceuticals, a drugmaker in Illinois. 

For about five years, federal auditors have enforced confusing requirements for residency programs, according to the American Society of Health-System Pharmacists, which released a toolkit April 18 to safeguard these programs. 

Emory Healthcare recently promoted Ryan Haumschild, PharmD, to the role of vice president of ambulatory pharmacy. 

After investigating the safety of CAR-T cell drugs, the FDA decided to include a serious risk on the boxed warnings of six approved immunotherapies. 

Community Health Systems' hospitals in Texas and Pennsylvania now stock epinephrine manufactured by Mark Cuban Cost Plus Drug Co.

Nearly 900 pharmacists are planning to demonstrate at 46 Walgreens locations in the Chicago area over the next month. 

Pharmacy workers at two CVS locations in Rhode Island have filed to unionize. The news comes less than a month after about 30 pharmacists and pharmacy technicians at a Las Vegas CVS Omnicare were the first in the industry to seek unionization. 

Senators are demanding to know why Novo Nordisk discontinued Levemir, one of the nation's three long-acting insulins. 

Morristown, N.J.-based Atlantic Health System will soon deploy an AI-based technology that flags polypharmacy issues, or problems related to taking five or more medications. 

With $159.4 billion, CVS Health accounts for a fourth of the U.S. pharmacy industry, according to 2023 prescription dispensing revenue data compiled by Drug Channels.